Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas

American Journal of Pathology

Volumn 150, Issue 5, 1997, Pages 1619-1629

  Bolon, Isabelle ^a   Devouassoux, Mojgan ^a   Robert, Catherine ^a   Moro, Denis ^a   Brambilla, Christian ^a   Brambilla, Elisabeth ^a,b  

^a Institut A Bonniot   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; METASTASIS POTENTIAL; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0030939074     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Sobin LH, Yesner R: Histological Typing of Lung Tumors: International Histological Classification of Tumors. Geneva, World Health Organization, 1981
2. Arrigoni M, Woolner L, Bernatz P: Atypical carcinoid tumors of the lung. J Thorac Surg 1972, 64:413-421
3. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB, Nieman L, Chrousos G, Pass H, Doppman J: Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol 1991, 15:529-553
4. Brambilla E, Moro D, Veale D, Brichon PY, Stoebner P, Paramelle B, Brambilla C: Basaloid carcinomas of lung a new phenotypic entity with prognosis significance. Hum Pathol 1992, 23:993-1003
5. Moro D, Brichon PY, Brambilla E, Veale D, Labat F, Brambilla C: Basaloid bronchial carcinoma: a histologic group with a poor prognosis. Cancer 1994, 73:2734-2739
6. Markus G, Takita H, Camiolo S, Corasanti J, Evers J, Hobika GH: Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. Cancer Res 1980, 40:841-848
7. Sappino AP, Busso N, Belin D, Vassali JD: Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res 1987, 47:4043-4046
8. Pedersen H, Brunner N, Francis D, Osterlind K, Ronne E, Hansen HH, Dano K, Grondahl-Hansen J: Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 1994, 54:4671-4675
9. Pedersen H, Grondahl-Hansen J, Francis D, Osterlind K, Hansen HH, Dano K, Brünner N: Urokinase and plasminogen activator inhibitor type I in pulmonary adenocarcinoma. Cancer Res 1994, 54:120-123
10. Ornstein DL, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Hunt J, Rousseau SM, Stump DC: Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues. Cancer 1991, 68:1061-1067
11. Oka T, Ishida T, Nishino T, Sugimachi K: Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma. Cancer Res 1991, 51:3522-3525
12. Gris JC, Scved JF, Marty-Double C, Mauboussin JM, Balmes P: Immunohistochemical study of tumor cell-associated plasminogen activators and plasminogen activator inhibitors in lung carcinomas. Chest 1993, 104:8-13
13. Nagayama M, Sato A, Hayakawa H, Urano T, Takada Y, Takada A: Plasminogen activators and their inhibitors in non-small cell lung cancer. Cancer 1994, 73:1398-1405
14. Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C, Brambilla E: Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 1995, 147:1298-1310
15. Dano K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C: The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994, 8:189-203
16. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesh H, Dumont P, Eber M, Abecassis J: Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 1991, 48:550-556
17. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, Kossakowska AE: Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 1992, 66:1188-1194
18. Anderson IC, Sugarbaker DJ, Ganju RK, Tsarwhas DJ, Richards WG, Sunday M, Kobzik L, Shipp MA: Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts. Cancer Res 1995, 55:4120-4126
19. Rouyer N, Wolf C, Chenard MP, Rio MC, Chambon P, Bellocq JP, Basset P: Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis 1994, 14:269-275
20. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq JP, Chambon P, Basset P: Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 1993, 90:1843-1847
21. Bolon I, Brambilla E, Vandenbunder B, Lantuejoul S, Robert C, Brambilla C: Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions. Lab Invest 1996, 75:1-13
22. Engel G, Heselmeyer K, Auer G, Bäckdahl M, Eriksson E, Linder S: Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int J Cancer 1994, 58:830-835
23. Pei D, Weiss SJ: Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995, 375:244-247
24. Marcotte PA, Kozan IM, Dorwin SA, Ryan JM: The matrix metalloproteinase Pump-1 catalyses formation of low molecular weight (pro)urokinase in culture of normal human kidney cells. J Biol Chem 1992, 267:13803-13806
25. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1994, 73:161-195
26. Mountain CF: A new international staging system for lung cancer. Chest 1986, 89:225-233
27. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990, 348:699-704
28. Muller D, Quantin B, Gesnel MC, Millon-Collard R, Abecassis J, Breathnach R: The collagenase gene family in humans consists of at least four members. Biochem J 1988, 253:187-192
29. McDonnel S, Navre M, Coffey RJ, Matrisian LM: Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinogen 1991, 4:527-533
30. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA, Stehelin D: Complementary patterns of expression of c-ets-1, c-myb, and c-myc in the blood forming system of the chick embryo. Development 1989, 107:265-274
31. Santavicca M, Noel A, Chenard MP, Lutz Y, Stoll I, Segain JP, Rouyer N, Rio MC, Wolf C, Bellocq JP, Basset P: Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry. Int J Cancer 1995, 64:336-341
32. Lorimier P, Lamarcq L, Guillermet C, Labat-Moleur F, Stoebner P: Enhanced chemiluminescence: a high-sensitivity detection system for in situ hybridization (ISH) and immunohistochemistry (ICH). J Histochem Cytochem 1993, 41:1591
33. Buisson AC, Gilles C, Polette M, Zahm JM, Birembaut P, Tournier JM: Wound repair-induced expression of stromelysins is associated with the acquisition of a mesenchymal phenotype in human respiratory epithelial cells. Lab Invest 1996, 74:658-669
34. Canete-Soler R, Litzky L, Lubensky l, Muschel RJ: Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J Pathol 1994, 144:518-527
35. Saarialhokere UK, Crouch EC, Parks WC: Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 1995, 105:190-196
36. Baker JB, Low DA, Simmer LR, Cunningham DD: Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980, 21:37-45
37. Low DA Baker JB, Koonce WC, Cunningham DD: Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases. Proc Natl Acad Sci USA 1981, 78:2340-2344
38. Pyke C, Graem N, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Brünner N, Dano K: Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 1993, 53:1911-1915
39. Pyke C, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Kirkeby L, Dano K: Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 1994, 24:131-138
40. Veale D, Needham G, Harris A: Urokinase receptors in lung cancer and normal lung. Anticancer Res 1990, 10:417-422
41. Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, Dano K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 1991, 138:1059-1067
42. Kristensen P, Eriksen J, Dano K: Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem 1991, 39:341-349
43. Lefebvre O, Wolf C, Limacher JM, Hutin P, Wendling C, Lemeur M, Basset P, Rio MC: The breast cancer-associated stromelysin-3 is expressed during mouse mammary gland apoptosis. J Cell Biol 1992, 119:997-1002
44. Kobayashi H, Fujishiro S, Terao T: Impact of urokinase-type plasminogen activator and its inhibitor type I on prognosis in cervical cancer of the uterus. Cancer Res 1994, 54:6539-6548
45. Visscher DW, Sarkar F, LoRusso P, Sakr W, Ottosen S, Wykes S, Crissman JD: Immunohistologic evaluation of invasion-associated proteases in breast carcinoma. Mod Pathol 1993, 6:302-306
46. Pei D, Majmudar G, Weiss SJ: Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 1994, 269:25849-25855